Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
9.60
+0.03 (0.31%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Surrozen Employees
As of December 31, 2024, Surrozen had 41 total employees, including 40 full-time and 1 part-time employees. The number of employees decreased by 1 or -2.38% compared to the previous year.
Employees
41
Change (1Y)
-1
Growth (1Y)
-2.38%
Revenue / Employee
$259,878
Profits / Employee
-$1,550,341
Market Cap
81.55M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41 | -1 | -2.38% |
Dec 31, 2023 | 42 | -32 | -43.24% |
Dec 31, 2022 | 74 | -9 | -10.84% |
Dec 31, 2021 | 83 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
SRZN News
- 21 days ago - Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 4 weeks ago - Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases - GlobeNewsWire
- 5 months ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 5 months ago - Surrozen Provides Third Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 6 months ago - Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 7 months ago - Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration - GlobeNewsWire
- 9 months ago - Surrozen Provides Second Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 11 months ago - Surrozen Publishes Study in ‘eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling - GlobeNewsWire